ACB - 2 Pot Stocks To Flat Out Avoid in 2022
Despite the dip last year, the marijuana industry consists of excellent growth stocks that have the potential to flourish in the coming years. The U.S. cannabis companies, in particular, saw drastic revenue growth amid the ongoing pandemic. The ramp-up of state legalization also gave a boost to marijuana sales.
However, not all stocks are worth considering. Some of the Canadian companies continued to disappoint investors. Canada-based Aurora Cannabis (NASDAQ: ACB) and Cronos Group (NASDAQ: CRON) are two Canadian pot stocks that have very few chances to recover this year. Here are the reasons you should avoid these two stocks in 2022.
Image source: Getty Images.
For further details see:
2 Pot Stocks To Flat Out Avoid in 2022